Retraction Note: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
Nat Commun. 2023 Dec 11;14(1):8193.
doi: 10.1038/s41467-023-43803-0.
1 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
2 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
3 Bayer Pharmaceuticals, Cambridge, MA, USA.
4 Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
5 Arpeggio, Boulder, CO, USA.
6 Department of Surgical Oncology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
7 Sanofi, Cambridge, MA, USA.
8 Department of Medicine, Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
9 Hale Family Center for Pancreatic Cancer Research, Dana-Farber Cancer Institute, Boston, MA, USA.
10 Department of Medicine, Division of Gastroenterology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
11 Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA, USA.
12 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [email protected].
13 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. [email protected].
14 Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA, USA. [email protected].